Seno Medical, Inc. was formed to commercialize a new modality in cancer screening and diagnosis: laser opto-acoustic imaging. Unlike most screening techniques, which rely on anatomical imaging, Seno's goal is to bring functional imaging that can detect angiogenesis to the marketplace. Our first product is a small animal imaging device, now in testing and scheduled for release in spring 2007. Products for use with humans, focusing initially on breast cancer, are also in development for subsequent testing.